非清晰细胞细胞癌:解开一个混乱的术语
Angelina Bania1,2, Giannicola Genovese1,2,3,4, Pavlos Msaouel1,2,4,5
1Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Clinical advances in hematology & oncology : H&O
|July 1, 2025
概括
非清细胞细胞癌 (nccRCC) 是一种多样化的罕见癌群. 本综述澄清了nccRCC亚型,超越一般术语,转向分子分类,以更好地诊断和治疗.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
- 遗传学 是一个遗传学.
背景情况:
- 非清晰细胞细胞癌 (nccRCC) 占瘤的很大一部分,但人们对其了解甚少.
- 许多nccRCC亚型是罕见的,具有攻击性,缺乏有效的,特定的治疗方法,通常需要从清晰细胞RCC试验中推断.
- 最近的进展是根据分子变化而不是仅仅基于形态来对瘤进行分类.
研究的目的:
- 要解构广义的nccRCC术语,并提出特定的子类型.
- 要突出nccRCC亚型的流行病学关联和独特的临床病理学特征.
- 确定在nccRCC的诊断,治疗和患者护理方面需要改进的领域.
主要方法:
- 关于脏瘤分类的当前文献的综合综述.
- 世界卫生组织对脏瘤实体的最新情况的分析.
- 对分子异常的检查 (例如,TFE3,FH,SDH) 定义了特定的nccRCC亚型.
主要成果:
- nccRCC是一个异质的类别,有许多罕见的亚型.
- 分子分类,包括基因异常,对于定义不同的实体越来越重要.
- 仅仅是形态学不足以区分许多nccRCC亚型.
结论:
- 转向基于分子的分类对于理解nccRCC至关重要.
- 对nccRCC亚型的详细表征将提高诊断准确度.
- 更好的理解将导致优化治疗策略和非清晰细胞细胞癌患者的治疗结果.
相关概念视频
Renal Drug Clearance: Overview
346
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
346
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K


